FIELD: process engineering.
SUBSTANCE: proposed map consists of multiple translucent chambers. Note here that every said chamber includes some quantity of tested material to be mixed with sample of patient to cause agglutination effects. Multiple indicators are arranged to facilitate fabrication and determination of map applicability before testing and be used in comprehensive classification of agglutination reactions caused or absence hereof.
EFFECT: higher reliability and accuracy.
12 cl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
IMMUNODIAGNOSTIC TESTING CHART WITH INDEX INDICATORS | 2012 |
|
RU2613195C2 |
IMMUNE MONITORING TEST ELEMENT WITH WEAKENED FOIL LAYER | 2009 |
|
RU2485497C2 |
SEPARATE CYCLIC CENTRIFUGING OF TEST ELEMENTS | 2009 |
|
RU2498316C2 |
SPACER FOR PREVENTING CONTAMINATION WITH REAGENT OR SOLUTION | 2001 |
|
RU2276358C2 |
METHOD FOR DETERMINING RESULT OF AGGLUTINATION REACTION AND MICROPLATE FOR DETERMINING PRODUCTS OF AGGLUTINATION REACTIONS | 2014 |
|
RU2648471C2 |
VESSEL TO CONDUCT QUANTITATIVE DETERMINATION OF AGGLUTINATION ( VARIANTS ) | 1997 |
|
RU2191382C2 |
APPARATUS AND METHOD OF DETECTING ANTIGENS OF BLOOD GROUPS BY INCOMPLETE ANTIBODY | 2015 |
|
RU2726452C2 |
METHOD FOR TITRATION OF GROUP ABO ANTIBODIES | 2013 |
|
RU2526820C1 |
COMBINED MEASURING SYSTEM TO ANALYSE SUBSTANCES IN BIOLOGICAL FLUIDS AND CARTRIDGES TO PERFORM COMBINED GENERAL CHEMICAL AND SPECIFIC ANALYSES OF BINDING | 2005 |
|
RU2377069C2 |
METHOD FOR DETERMINING POSTTRANSPLANTATION CHIMERISM IN COURSE OF STUDY OF ABO SYSTEM ERYTHROCYTE ANTIGENS | 2020 |
|
RU2758064C1 |
Authors
Dates
2012-12-10—Published
2009-01-15—Filed